The updated shots target an omicron subvariant called XBB.1.5 and were cleared Monday by the FDA

⭕️ Gifted Article 
https://wapo.st/3sOy8G9

(A third shot, made by Novavax, is still under review)

Several members of the advisory panel said they supported a universal recommendation because the vaccines work against current and emerging virus variants, provide benefit across all age groups, and increase access.

https://files.mastodon.social/media_attachments/files/111/055/919/367/949/447/original/c51ea7496ca683bf.jpg

https://files.mastodon.social/media_attachments/files/111/055/919/536/993/336/original/320878ca02372d98.jpg